ClinicalTrials.Veeva

Menu

Class iv Versus Class Iiib Laser Therapy on Median Sternotomy Healing After Coronary Artery Bybass Graft (wounds)

H

Heidy F. Ahmed

Status

Completed

Conditions

Wound
Wound Heal
Wound Infection

Treatments

Device: laser therapy for wound management

Study type

Interventional

Funder types

Other

Identifiers

NCT05853237
P.T.REC/012/003308

Details and patient eligibility

About

LASER therapy is potent physiotherapy modalities, providing better sternotomy healing for patients who have undergone CABG surgery, compared with traditional wound care management alone. HLLT and LLLT were found to be the most effective methods for sternotomy healing post-CABG surgery, with HLLT offering superior performance in the case of the high deep penetration and significance less time needed to deliver the same joules/ cm compared to LLLT used for the wound site.

Full description

The aim of this study was to investigate the effects of class IV high-level laser therapy (HLLT) versus class IIIb low level laser therapy (LLLT) on sternotomy healing following coronary artery bypass grafting (CABG) surgery. Forty- five patients male patients who had CABG surgery in the age range of 45-65 years were divided randomly into three equal groups (n = 15). The group HLLT laser received HLLT plus traditional wound management, while the group LLLT laser received LLLT plus traditional wound management. The control group only received a traditional wound management in form of saline irrigation, dressing, and topical bivatracin spray according to hospital protocol. All groups were offered 10 sessions over 4 weeks. HLLT and LLLT were found to be the most effective methods for sternotomy healing post-CABG surgery, with HLLT offering superior performance in the case of the high deep penetration and significance less time needed to deliver the same joules/ cm compared to LLLT used for the wound site.

Enrollment

45 patients

Sex

Male

Ages

45 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged between 45 and 65 years
  • male gender; haemodynamic stability
  • body mass index (BMI) from 18.5 to 29.9 kg/m2
  • Non-infected sternotomy site
  • Normal ejection fraction to ensure normal vascularity.

Exclusion criteria

  • included previous thoracic surgery
  • emergency or urgent coronary artery bypass surgery
  • respiratory insufficiency after surgery, manifesting hypoxemia with partial oxygen pressure in arterial blood < 60 mmHg; Ejection fraction < 50%
  • Paramedian sternotomy which may cut wire causing sternal mobilization which is the start of deep wound infection
  • Bilateral mammary harvesting which decrease blood flow to sternum; low cardiac output syndrome with ST segment elevation in multiple electrocardiogram leads, cardiac arrhythmias or hypotension, according to the American College of Cardiology Foundation and American Heart Association
  • other medical conditions, such as diabetes, uncontrolled hypertension and obesity.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

45 participants in 3 patient groups

class IV group
Experimental group
Description:
start from day one surgery for 4 successive weeks, the goal in the phase I (1st 10 days after surgery) is decontamination, improve circulation, pain reduction \&wound healing acceleration The goal of phase II (next10 days till complete healing) is improve osteo-integration, pain reduction \& enhance superficial collagen production to decrease scarring. The parameters are: Power \> 500 mW; fluence 20 joule/ cm2 with (980, 915, 810 nm) and 5 joules/ cm2 by 650 nm; mode (continuous); hand piece radius = 2.5 cm; spot size (Area) = 5 cm; application by scanning not spotting to avoid thermal effect and time of session is 5- 10 minutes
Treatment:
Device: laser therapy for wound management
class IIIb
Experimental group
Description:
Use the same protocol as in HLLT with the same wave lengths but with low power Power = 200- 300 mW; fluence 20 joule/ cm2 with (980, 915, 810 nm) and 5 joules/ cm2 by 650 nm; mode (continuous); hand piece radius = 2.5 cm; spot size (Area) = 5 cm; application by spotting and time of session was 25- 30 minutes.
Treatment:
Device: laser therapy for wound management
traditional wound care
Active Comparator group
Description:
According to the hospital protocol Irrigation of the wound by normal saline, betadine application, bivatracin spray and Change dressing daily to protect the wound from infection
Treatment:
Device: laser therapy for wound management

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems